中国临床营养杂志
中國臨床營養雜誌
중국림상영양잡지
CHINESE JOURNAL OF CLINICAL NUTRITION
2000年
1期
62-63
,共2页
徐鹏远%陈加勇%许世才%谭晶%王兴贤
徐鵬遠%陳加勇%許世纔%譚晶%王興賢
서붕원%진가용%허세재%담정%왕흥현
目的了解营养支持和生长抑素对重症胰腺炎的治疗作用.方法近2年来对10例重症胰腺炎给予营养支持和生长激素治疗(治疗组),并与早期仅用TPN支持的10例重症胰腺炎(对照组)进行比较.所有病人均经淀粉酶、B超、CT及腹腔穿刺液确诊,根据APACHEⅡ评分,>9分为重症胰腺炎.结果两组病人各有1例死亡,差异无显著性,但治疗组并发症较少,住院时间缩短,与对照组比较差异有显著性P<0.05.结论1.重症胰腺炎是肠外营养支持的适应证,而轻型胰腺炎可不必给予肠外营养支持,因此急性胰腺炎的临床分级是十分重要的,APACHⅡ评分能较全面地对此作出评价.2.PN能改善重症胰腺炎病人的营养状态,减少胰腺和消化液的分泌,但并不能达到理想的效果.3.生长抑素能明显抑制胰腺及消化道分泌,与PN合用能减少病人并发症发生率,缩短住院时间.4.应注意保护重症胰腺炎的胃肠道粘膜屏障功能,这对阻断或减轻全身炎性反应综合症有重要意义,早期少量口服谷氨酰胺是可取的,且未见增加胰腺负担,有条件者静脉给予足量谷氨酰双肽更好.5.急性胰腺炎病重期给予静脉输注血浆白蛋白十分重要,它能强化PN治疗,及时提高血浆胶体渗透压,发挥白蛋白运输和抗氧化等生理作用.6.手术病人应置空肠造瘘,以便能早期开始肠内营养,要素饮食经空肠给予无明显胰腺刺激作用.合理的营养支持加生长抑素对重症胰腺炎能改善机体营养状态,进一步减少胰腺分泌,降低重症胰腺炎的并发症,缩短住院时间.
目的瞭解營養支持和生長抑素對重癥胰腺炎的治療作用.方法近2年來對10例重癥胰腺炎給予營養支持和生長激素治療(治療組),併與早期僅用TPN支持的10例重癥胰腺炎(對照組)進行比較.所有病人均經澱粉酶、B超、CT及腹腔穿刺液確診,根據APACHEⅡ評分,>9分為重癥胰腺炎.結果兩組病人各有1例死亡,差異無顯著性,但治療組併髮癥較少,住院時間縮短,與對照組比較差異有顯著性P<0.05.結論1.重癥胰腺炎是腸外營養支持的適應證,而輕型胰腺炎可不必給予腸外營養支持,因此急性胰腺炎的臨床分級是十分重要的,APACHⅡ評分能較全麵地對此作齣評價.2.PN能改善重癥胰腺炎病人的營養狀態,減少胰腺和消化液的分泌,但併不能達到理想的效果.3.生長抑素能明顯抑製胰腺及消化道分泌,與PN閤用能減少病人併髮癥髮生率,縮短住院時間.4.應註意保護重癥胰腺炎的胃腸道粘膜屏障功能,這對阻斷或減輕全身炎性反應綜閤癥有重要意義,早期少量口服穀氨酰胺是可取的,且未見增加胰腺負擔,有條件者靜脈給予足量穀氨酰雙肽更好.5.急性胰腺炎病重期給予靜脈輸註血漿白蛋白十分重要,它能彊化PN治療,及時提高血漿膠體滲透壓,髮揮白蛋白運輸和抗氧化等生理作用.6.手術病人應置空腸造瘺,以便能早期開始腸內營養,要素飲食經空腸給予無明顯胰腺刺激作用.閤理的營養支持加生長抑素對重癥胰腺炎能改善機體營養狀態,進一步減少胰腺分泌,降低重癥胰腺炎的併髮癥,縮短住院時間.
목적료해영양지지화생장억소대중증이선염적치료작용.방법근2년래대10례중증이선염급여영양지지화생장격소치료(치료조),병여조기부용TPN지지적10례중증이선염(대조조)진행비교.소유병인균경정분매、B초、CT급복강천자액학진,근거APACHEⅡ평분,>9분위중증이선염.결과량조병인각유1례사망,차이무현저성,단치료조병발증교소,주원시간축단,여대조조비교차이유현저성P<0.05.결론1.중증이선염시장외영양지지적괄응증,이경형이선염가불필급여장외영양지지,인차급성이선염적림상분급시십분중요적,APACHⅡ평분능교전면지대차작출평개.2.PN능개선중증이선염병인적영양상태,감소이선화소화액적분비,단병불능체도이상적효과.3.생장억소능명현억제이선급소화도분비,여PN합용능감소병인병발증발생솔,축단주원시간.4.응주의보호중증이선염적위장도점막병장공능,저대조단혹감경전신염성반응종합증유중요의의,조기소량구복곡안선알시가취적,차미견증가이선부담,유조건자정맥급여족량곡안선쌍태경호.5.급성이선염병중기급여정맥수주혈장백단백십분중요,타능강화PN치료,급시제고혈장효체삼투압,발휘백단백운수화항양화등생리작용.6.수술병인응치공장조루,이편능조기개시장내영양,요소음식경공장급여무명현이선자격작용.합리적영양지지가생장억소대중증이선염능개선궤체영양상태,진일보감소이선분비,강저중증이선염적병발증,축단주원시간.
Objective To evaluate the effect of Nutrtion Support with Somatostatin for patients with severe pancreantitis (Acute Hemorrhagic pancreantitis). Methods In a two years period, we selected 20 patients with severe pancreantitis, and divided them into two groups randomly. In group A (the treating group), we used TPN Plus Somatostatin, In group B (the control group) ,we just used the traditionalTPN support. All the patients in the study were diagnosed by serum amylase, ultrasound detection, CT and peritoneocentesis. Their APACH Ⅱ score were all above 9 and confirm to be severe pancreantitis. Results There was one patient died in each group, the mortality was no significant. But the occurrence of complications of group A Was decreased, and the length of in hospital was stay shortened (P<0.05). Conclusions 1. TPN could meet the hypermetabolic need of the patients with severe pancreantitis, but it was not necessary for those who just had moderate acute pancreantitis. So the APACH Ⅱ Grade was very important to condition assessment and the selection of candidates for TPN. 2. PN could improve the nutrition state of the patients with severe pancreantitis, reduce the excretion of pancreas and other digestive glands, but it could not achieve the best results for signle using. 3. Somatostatin could obviously compress the excretion of pancreas and digestive tracts, the administration of it plus PN can cut down the occurrence of complication and shorten the treating days. 4. To protect the gastric and intestind mucous barrier is crucial, it would be helpful in obstructing and alleviate the Systemic Inflammatory Response Syndrome (SIRS). We have observed that taking low-dose glutamine in early stage of severe pancreantitis didn't aggravate the burden of pancreas, and the intravenous injection of dipeptid glutamine had much better results. 5. It was also important for severe patients to be given plasma albumin by intravenous drops. It could strengthen the effect of PN, heighten the Plasmatic Colloid Osmotic Pressure, and had the effect of transportation and anti-oxidation. 6. The patients scheduled for operations had better to have jejunostomy so as to use enteral nutrtition earlier, and the elemental nutrition given through the jejunum had little stimulation to pancreas. Rational administration of TPN with somatostatin can improve the nutritional status of the patients with severe pancreantitis, decrease the excretion of pancreas and shorten the treating days.